Skip to content

Skin Imaging With Technologies in Development

Non-invasive Imaging Modalities for Assessment of Normal and Lesional Skin

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00764920
Enrollment
750
Registered
2008-10-02
Start date
2008-10-01
Completion date
2027-12-01
Last updated
2026-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pigmented Skin Lesion of Uncertain Nature

Keywords

human skin

Brief summary

The purpose of this research is to develop non-invasive imaging modalities for assessment of skin. This is a pilot study which will use multiple imaging modalities to collect information on normal and lesional skin. The researchers understand that the purpose of this study is not to evaluate any particular treatment and an investigation of a new therapeutic intervention would require an additional protocol. Skin conditions to be studied include vascular lesions, pigmentary disorders, inflammatory conditions and neoplasms.

Detailed description

Normal and lesional skin will be assessed by the following imaging modalities: 1. Laser Speckle Imaging can provide information about relative blood flow in a tissue. In skin it can be used to determine what areas have more blood flow and whether a particular intervention or treatment affects blood flow. 2. Optical Coherence Tomography and Optical Doppler Tomography can provide pictures of blood vessels in an area of the body and can also tell how fast blood is flowing in that area. 3. Photon Migration Spectroscopy can provide information about the amount of blood, oxygen, fat and water is in a tissue. 4. Multi-Spectral Imaging can provide a 3 dimensional image of structures within the skin. 5. Multiphoton Microscopy can provide images of structures of the skin.

Interventions

DEVICEnon-invasive imaging modalities for assessment of skin

skin imaging

Sponsors

University of California, Irvine
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
7 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* adult male or female 7 and older; able to carry out study instructions

Exclusion criteria

* Younger than 7 years old * pregnant woman * breast feeding

Design outcomes

Primary

MeasureTime frameDescription
Collect information on normal and lesional skinup to 12 weeksDevelop non-invasive imaging modalities for assessment of skin.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORKristen M Kelly, MD

Beckman Laser Institute University of California Irvine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 6, 2026